The Singapore-based Hilleman Laboratories announced it would advance the rVSV Bundibugyo jab so it can be tested on humans during clinical trials.

The Singapore-based Hilleman Laboratories announced it would advance the rVSV Bundibugyo jab so it can be tested on humans during clinical trials.

Hilleman Laboratories, sebuah perusahaan patungan yang berbasis di Singapura bersiap untuk memproduksi dosis vaksin eksperimental untuk Ebola.